AI Biotech/Longevity Heats Up: Astromech Hits $3.8B Valuation

Ben Lamm's Astromech (Colossal AI spinoff) raises $20M at $3.8B valuation, targeting aging with genomic AI models. Only $60M total raised—massive investor conviction. Signals continued appetite for ambitious deep-tech AI plays in biology.